Dr. Michael J. Castine
Claim this profileHematology Oncology Clinic
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
16 reported clinical trials
32 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage IV
PD-L1 positive
2Lung Cancer
Stage III
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Michael J. Castine is currently running
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
ARX788
for HER2-Positive Breast Cancer
This trial tests ARX788, a new IV medicine, for patients with HER2-positive metastatic breast cancer who did not respond well to T-DXd. The medicine targets a specific protein on cancer cells to help stop their growth.
Recruiting1 award Phase 28 criteria
More about Michael J. Castine
Clinical Trial Related3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Michael J. Castine has experience with
- Fruquintinib
- Pembrolizumab
- PD-1 Inhibitor
- ARX788
- Abemaciclib
- LOXO-305
Breakdown of trials Michael J. Castine has run
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael J. Castine specialize in?
Michael J. Castine focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Michael J. Castine currently recruiting for clinical trials?
Yes, Michael J. Castine is currently recruiting for 6 clinical trials in Baton Rouge Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Michael J. Castine has studied deeply?
Yes, Michael J. Castine has studied treatments such as Fruquintinib, Pembrolizumab, PD-1 inhibitor.
What is the best way to schedule an appointment with Michael J. Castine?
Apply for one of the trials that Michael J. Castine is conducting.
What is the office address of Michael J. Castine?
The office of Michael J. Castine is located at: Hematology Oncology Clinic, Baton Rouge, Louisiana 70809 United States. This is the address for their practice at the Hematology Oncology Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.